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Brains on Batteries: The Potential of
Deep Brain Stimulation
By Joshua Pandian

For 40 years of her life, Edi Guyton could not experience happiness. Despite having a family and a successful career, she still struggled to feel happy. She
tried various therapies and medications, but to no
avail. Then, in 2007, Edi Guyton underwent an experimental procedure that allowed her to smile genuinely
for the first time in her life. Due to two electrodes
implanted in her brain and a small battery pack near
her collar bone, Edi is now able to experience the joys
of life like everyone else.10 Deep brain stimulation
(DBS), the process of implanting electrodes into the
brain to lessen the symptoms of neurological diseases, began as an experimental idea based on early
pain-processing theories. Today, DBS is used to treat
various neurological disorders, including Parkinson’s
disease, depression, OCD, and chronic pain. While
major advancements have been made in recent
years, DBS is still in its infancy and possesses a tremendous potential to advance human well-being as
our knowledge of neuroscience increases.

process, in which pain signals are processed via the
spinal cord before reaching the brain. Then, in 1969,
D.V. Reynolds discovered a top-down process in
which the brain receives pain signals first and proceeds to inhibit them. In his study, Reynolds stimulated the periaqueductal gray regions in the midbrain of
rats and performed surgery on them without anesthesia. The rats felt no pain for the duration of the
surgery.3 This phenomenon occurs because the periaqueductal gray region has associations with nerve
fibers that send signals to the dorsal horn of the spinal cord, the same area where pain is inhibited during
gate-control.2 Reynold’s study demonstrated that the
brain also has the ability to inhibit pain.

With the knowledge that pain can be inhibited from
the spinal cord or from the midbrain, researchers
attempted to cure chronic pain using two approaches. The first approach is spinal cord stimulation,
which involves placing electrodes in the spinal cord to
generate a pulse to keep pain signals from reaching
the brain. This method of treating pain was originally
The History of Deep Brain Stimulation
believed to work due to gate-control theory, but curThe discovery of deep brain stimulation began in
rently research has shown that there may be more
1965 when Ronald Melzak and Patrick Wall proposed factors at play. Essentially, the added electrical sigtheir gate-control theory of pain. Through their stud- nals from the electrodes inhibit the pain signals from
ies, Melzak and Wall discovered that nerve fibers that reaching the brain.5 As a result of its success, spinal
transmit information about touch and vibration are
cord stimulation was FDA approved and used as a
more myelinated, and therefore faster acting than
method for pain relief.3
nerve fibers that transmit pain signals. In the dorsal
horn of the spinal cord, these fast-acting nerve fibers The second method used to cure chronic pain was
can inhibit pain signals from reaching the brain. The DBS, which was originally proposed in the 1970s.
gate-control theory explains why we tend to rub our Electrodes were placed in the thalamus, the part of
head when we hit it on a doorframe or grab our foot the brain responsible for directing pain signals for the
somatosensory cortex for processing. Unfortunately,
when we step on a Lego. Increasing touch signals
3
clinical trials did not produce convincing evidence for
helps inhibit pain.
the effectiveness of DBS.3 Today, we know this is beThe gate-control theory of pain gave rise to ideas
cause the original trials were poorly executed,4 but at
about how pain can be controlled from a bottom-up the time, it appeared DBS had reached an end.
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DBS seemed to be a failed idea until the 1980s, when
it was found to be effective in countering motor
symptoms associated with Parkinson’s disease.3 Increased knowledge of the brain regions associated
with Parkinson’s disease allowed scientists to better
target areas to stimulate to help counter irregular
activity. Even today, our knowledge of these brain
regions continues to expand. For instance, a 2018
study on the interactions between the basal ganglia
and thalamus revealed that in low dopamine environments, inhibitory output from the basal ganglia
can cause rebound firing in the thalamus, leading to
motor symptoms associated with Parkinson’s disease.6 Modulating basal ganglia output or the rebound firing can help eliminate involuntary muscle
contractions, so DBS can potentially be the answer to
this problem.

Where is DBS Today?
After DBS was first approved in 1997, the applications of it have expanded beyond Parkinson’s disease. One example of this is the use of DBS to treat
certain types of depression. In 2005, Dr. Helen Mayberg used DBS on Brodmann area 25, a part of the
brain that has been identified as overactive in individuals with treatment resistant depression. According to the study, stimulating this region with electrodes can help decrease activity in the region, which
in turn affects the hypothalamus and the brainstem.
For patients receiving this treatment, this means
better sleep, motivation, and energy. As this study
shows, DBS is effective because it modulates multiple
functions in the brain by changing processes in the
target site and downstream.7
Patients suffering from obsessive compulsive disorder (OCD) may also be able to benefit from DBS. A
recent study showed that targeting one of five possible brain areas can relieve OCD symptoms. However,
it appears that stimulating the different regions have
different impacts on the brain, so a more personalized approach must be taken to provide the appropriate treatment to each patient.8
Advances in using personalized DBS techniques have
led researchers to again attempt combating chronic
pain with DBS. Dr. Shirvalkar, an associate professor
of anesthesiology at UC San Francisco, is using the

technology available today to monitor neural activity
over time in order to create DBS with varying electrical pulses depending on the situation.9 Studies such
as these show promise for DBS to be more accurate
and effective in the future.

What still needs to be done?
Although DBS is becoming more effective over time,
there is still plenty of room for improvement. One of
the biggest challenges facing the advancement of
DBS is the current lack of understanding about how
certain brain functions interact. While research can
often get general ideas for what different brain regions do, it is still difficult to target which area to
place the electrodes in order to have effective DBS.
This is seen from the studies of DBS on OCD, where
treatments of multiple brain regions appear to ease
symptoms, but in different ways.8 Also, in some cases, a patient’s brain can become used to the deep
brain stimulation, thus rendering the treatment ineffective. More research must be done in order to
understand why DBS may cease to work in some patients.1 As research on the topic expands, patients
will benefit from having DBS that is more personalized and effective in treating their specific condition.
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